Entrada Therapeutics shares owned by Deutsche Bank Aktiengesellschaft
Quarter-by-quarter ownership of Entrada Therapeutics (TRDA) shares owned by Deutsche Bank Aktiengesellschaft
from 13F filings
Historical chart of Deutsche Bank Aktiengesellschaft investment in Entrada Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Entrada Therapeutics held by Deutsche Bank Aktiengesellschaft consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Entrada Therapeutics by Deutsche Bank Aktiengesellschaft
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $122k | 21k | 5.80 |
| 2025-06-30 | $104k | 16k | 6.72 |
| 2025-03-31 | $176k | 20k | 9.04 |
| 2024-12-31 | $376k | 22k | 17.29 |
| 2024-09-30 | $223k | 14k | 15.98 |
| 2024-06-30 | $146k | 10k | 14.25 |
| 2024-03-31 | $143k | 10k | 14.17 |
| 2023-12-31 | $148k | 9.8k | 15.09 |
| 2023-09-30 | $159k | 10k | 15.80 |
| 2023-06-30 | $129k | 8.5k | 15.14 |
| 2022-03-31 | $47k | 5.0k | 9.48 |
| 2021-12-31 | $95k | 5.6k | 17.06 |
More positions owned by Deutsche Bank Aktiengesellschaft
View all positions for Deutsche Bank Aktiengesellschaft